Effects of dietary supplements on aspirin and other antiplatelet agents: An evidence-based approach

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 87-101

  Desai, Ditina ^a   Hasan, Ahmed ^b   Wesley, Robert ^a   Sunderland, Edwin ^a   Pucino, Frank ^a   Csako, Gyorgy ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; CALCIUM CARBONATE; CLOPIDOGREL; COD LIVER OIL; DIPYRIDAMOLE; DOCOSAHEXAENOIC ACID; GINKGO BILOBA EXTRACT; ICOSAPENTAENOIC ACID; KAOLIN PECTIN; LEVONORGESTREL; LINSEED OIL; MAGNESIUM OXIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLICOSANOL; TICLOPIDINE;

AREA UNDER THE CURVE; BIOAVAILABILITY; BLOOD CLOTTING; CLINICAL TRIAL; COCHRANE LIBRARY; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; DATA ANALYSIS; DIET SUPPLEMENTATION; DRUG FATALITY; EMBASE; EPISTAXIS; EVIDENCE BASED MEDICINE; FIBRINOLYSIS; FOOD DRUG INTERACTION; GINGIVA BLEEDING; GINKGO BILOBA; HEMATOMA; HEMATURIA; HUMAN; HYPHEMA; INGUINAL REGION; MEDLINE; PRIORITY JOURNAL; STROKE; TAMARIND; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY;

ASPIRIN; CLINICAL TRIALS; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; PLATELET AGGREGATION INHIBITORS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 27744554377     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.06.017     Document Type: Conference Paper

References (61)

1. American Heart Association. Heart disease and stroke statistics-2005 update. [Accessed Apr 1, 2005 at http:// www.americanheart.org/downloadable/ heart/1105390918119HDSStats2005Update ].
2. Prevalence of disabilities and associated health conditions among adults-United States, 1999 MMWR 50 2001 120 125
3. J. Ness, and W.S. Aronow Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice J Am Geriatr Soc 47 1999 1255 1256
4. P.A. Rochon, and J.H. Gurwitz Prescribing for seniors: neither too much nor too little JAMA 282 1999 113 115
5. R.S. Stafford Aspirin use is low among United States outpatients with coronary artery disease Circulation 101 2000 1097 1101
6. S.J Bredie, H. Wollersheim, F.W. Verheugt, and T. Thien Low-dose aspirin for primary prevention of cardiovascular disease Semin Vasc Med 3 2003 177 184
7. P.M. Ridker, N.R. Cook, I.M. Lee, D. Gordon, J.M. Gaziano, and J.E. Manson A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women N Engl J Med 352 2005 1293 1304
8. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, and M. Van Rompay Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 1998 1569 1575
9. K. Radimer, B. Bindewald, J. Hughes, B. Ervin, C. Swanson, and M.F. Picciano Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000 Am J Epidemiol 160 2004 339 349
10. C.C. Peng, P.A. Glassman, L.E. Trilli, J. Hayes-Hunter, and C.B. Good Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices Arch Intern Med 164 2004 630 636
11. R. Marchioli, C. Schweiger, L. Tavazzi, and F. Valagussa Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico Lipids 36 2001 S119 S126 [Suppl]
12. K. He, E.B. Rimm, A. Merchant, B.A. Rosner, M.J. Stampfer, and W.C. Willett Fish consumption and risk of stroke in men JAMA 288 2002 3130 3136
13. H. Iso, K.M. Rexrode, M.J. Stampfer, J.E. Manson, G.A. Colditz, and F.E. Speizer Intake of fish and omega-3 fatty acids and risk of stroke in women JAMA 285 2001 304 312
14. M. Sacco, F. Pellegrini, M.C. Roncaglioni, F. Avanzini, G. Tognoni, and A. Nicolucci Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial Diabetes Care 26 2003 3264 3272
15. E. Guallar, C.H. Hennekens, F.M. Sacks, W.C. Willett, and M.J. Stampfer A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians J Am Coll Cardiol 25 1995 387 394
16. C.M. Albert, C.H. Hennekens, C.J. O'Donnell, U.A. Ajani, V.J. Carey, and W.C. Willett Fish consumption and risk of sudden cardiac death JAMA 279 1998 23 28
17. U.M. Frieling, D.A. Schaumberg, T.S. Kupper, J. Muntwyler, and C.H. Hennekens A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study Arch Dermatol 136 2000 179 184
18. S. Liu, M.J. Stampfer, F.B. Hu, E. Giovannucci, E. Rimm, and J.E. Manson Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study Am J Clin Nutr 70 1999 412 419
19. K.G. Losonczy, T.B. Harris, and R.J. Havlik Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly Am J Clin Nutr 64 1996 190 196
20. T.W. Faust, J.S. Redfern, I. Podolsky, E. Lee, S.M. Grundy, and M. Feldman Effects of aspirin on gastric mucosal prostaglandin E2 and F2 alpha content and on gastric mucosal injury in humans receiving fish oil or olive oil Gastroenterology 98 1990 586 591
21. P. Prichard, G. Brown, N. Bhaskar, and C. Hawkey The effect of dietary fatty acids on the gastric production of prostaglandins and aspirin-induced injury Aliment Pharmacol Ther 2 1988 179 184
22. K.G. Yeoh, J.Y. Kang, I. Yap, R. Guan, C.C. Tan, and A. Wee Chili protects against aspirin-induced gastroduodenal mucosal injury in humans Dig Dis Sci 40 1995 580 583
23. A. Suehiro, S. Higasa, M. Ueda, and Y. Oura Combination effect of eicosapentaenoic acid and platelet suppressive agents on platelets Curr Ther Res 55 1994 653 659
24. G.J. Dehmer, J.J. Popma, E.K. van den Berg, E.J. Eichhorn, J.B. Prewitt, and W.B. Campbell Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids N Engl J Med 319 1988 733 740
25. D.I. Gruver Does flaxseed interfere with the clotting system? Plast Reconstr Surg 112 2003 934
26. M. Rosenblatt, and J. Mindel Spontaneous hyphema associated with ingestion of Ginkgo biloba extract N Engl J Med 336 1997 1108
27. M.L. Arruzazabala, S. Valdes, R. Mas, D. Carbajal, and L. Fernandez Comparative study of policosanol, aspirin and the combination therapy policosanol-aspirin on platelet aggregation in healthy volunteers Pharmacol Res 36 1997 293 297
28. K. Engstrom, R. Wallin, and T. Saldeen Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids Prostaglandins Leukot Essent Fat Acids 64 2001 291 297
29. W.S. Harris, S. Silveira, and C.A. Dujovne The combined effects of n-3 fatty acids and aspirin on hemostatic parameters in man Thromb Res 57 1990 517 526
30. L. Iacoviello, C. Amore, A. De Curtis, M.T. Tacconi, G. de Gaetano, and C. Cerletti Modulation of fibrinolytic response to venous occlusion in humans by a combination of low-dose aspirin and n-3 polyunsaturated fatty acids Arterioscler Thromb 12 1992 1191 1197
31. R.P. Juhl Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption Am J Hosp Pharm 36 1979 1097 1098
32. B.A. Mueller, R.L. Talbert, C.H. Tegeler, and T.J. Prihoda The bleeding time effects of a single dose of aspirin in subjects receiving omega-3 fatty acid dietary supplementation J Clin Pharmacol 31 1991 185 190
33. A. Mustapha, I.A. Yakasai, and I.A. Aguye Effect of Tamarindus indica L. on the bioavailability of aspirin in healthy human volunteers Eur J Drug Metab Pharmacokinet 21 1996 223 226
34. M. Steiner Effect of alpha-tocopherol administration on platelet function in man Thromb Haemost 49 1983 73 77
35. N. Svaneborg, S.D. Kristensen, L.M. Hansen, I. Bullow, S.E. Husted, and E.B. Schmidt The acute and short-time effect of supplementation with the combination of n-3 fatty acids and acetylsalicylic acid on platelet function and plasma lipids Thromb Res 105 2002 311 316
36. M. Thorngren, and A. Gustafson Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation Lancet 2 1981 1190 1193
37. M. Thorngren, A. Gustafson, and G. Wohlfart Effects of acetylsalicylic acid on platelet aggregation before and during increase in dietary eicosapentaenoic acid Haemostasis 13 1983 244 247
38. J. Eritsland, H. Arnesen, P. Smith, I. Seljeflot, and K. Dahl Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile J Oslo City Hosp 39 1989 97 101
39. K.E. Liede, J.K. Haukka, L.M. Saxen, and O.P. Heinonen Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid Ann Med 30 1998 542 546
40. C. d'Arcangues, G. Piaggio, V. Brache, R.B. Aissa, C. Hazelden, and R. Massai Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding Contraception 70 2004 451 462
41. R. Stusser, J. Batista, R. Padron, F. Sosa, and O. Pereztol Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients Int J Clin Pharmacol Ther 36 1998 469 473
42. M. Steiner, M. Glantz, and A. Lekos Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks Am J Clin Nutr 62 1995 1381S 1384S
43. J. Eritsland, H. Arnesen, K. Gronseth, N.B. Fjeld, and M. Abdelnoor Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency Am J Cardiol 77 1996 31 36
44. L.E. Grigg, T.W. Kay, P.A. Valentine, R. Larkins, D.J. Flower, and E.G. Manolas Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty J Am Coll Cardiol 13 1989 665 672
45. U. Kaul, S. Sanghvi, V.K. Bahl, V. Dev, and H.S. Wasir Fish oil supplements for prevention of restenosis after coronary angioplasty Int J Cardiol 35 1992 87 93
46. S. Warren, E. Siguel, E. Gervino, E.W. Salzman, K. Silverman, and R. Pasternak Effects of cod liver oil on plasma lipids, eicosanoids, platelet aggregation, and exercise in stable angina pectoris J of App Cardiol 3 1988 227 236
47. M. Shechter, C.N. Merz, M. Paul-Labrador, S.R. Meisel, R.K. Rude, and M.D. Molloy Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease Am J Cardiol 84 1999 152 156
48. T. Force, R. Milani, P. Hibberd, R. Lorenz, W. Uedelhoven, and A. Leaf Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile Circulation 84 1991 2286 2293
49. F. Gaspari, G. Vigano, M. Locatelli, and G. Remuzzi Influence of antacid administrations on aspirin absorption in patients with chronic renal failure on maintenance hemodialysis Am J Kidney Dis 11 1988 338 342
50. S.L. Connor, and W.E. Connor Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 66 1997 1020S 1031S
51. S.H. Goodnight Jr. The vascular effects of omega-3 fatty acids J Invest Dermatol 93 1989 102S 106S
52. J.M. Zingg, and A. Azzi Non-antioxidant activities of vitamin E Curr Med Chem 11 2004 1113 1133
53. J.J. Corrigan Jr., and LL. Ulfers Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency Am J Clin Nutr 34 1981 1701 1705
54. D. Carbajal, M.L. Arruzazabala, S. Valdes, and R. Mas Effect of policosanol on platelet aggregation and serum levels of arachidonic acid metabolites in healthy volunteers Prostaglandins Leukot Essent Fat Acids 58 1998 61 64
55. J.T. Chen, R. Wesley, R.D. Shamburek, F. Pucino, and G. Csako Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol Pharmacotherapy 25 2005 171 183
56. H.B. Ravn, H. Vissinger, S.D. Kristensen, and SE. Husted Magnesium inhibits platelet activity-an in vitro study Thromb Haemost 76 1996 88 93
57. H.B. Ravn, H. Vissinger, S.D. Kristensen, A. Wennmalm, K. Thygesen, and S.E. Husted Magnesium inhibits platelet activity-an infusion study in healthy volunteers Thromb Haemost 75 1996 939 944
58. V.L. Serebruany, S.R. Steinhubl, P.B. Berger, A.I. Malinin, J.S. Baggish, and D.L. Bhatt Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials Am J Cardiol 95 2005 1218 1222
59. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
60. Steinhubl SR. Resistance to antiplatelet resistance. J Am Coll Cardiol 45 [in press].
61. P.A. Gum, K. Kottke-Marchant, P.A. Welsh, J. White, and E.J. Topol A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J Am Coll Cardiol 41 2003 961 965